763 related articles for article (PubMed ID: 15625214)
1. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
3. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
4. Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder.
Foa EB; Simpson HB; Liebowitz MR; Powers MB; Rosenfield D; Cahill SP; Campeas R; Franklin M; Hahn CG; Hembree EA; Huppert JD; Schmidt AB; Vermes D; Williams MT
J Clin Psychiatry; 2013 May; 74(5):464-9. PubMed ID: 23759449
[TBL] [Abstract][Full Text] [Related]
5. Response versus remission in obsessive-compulsive disorder.
Simpson HB; Huppert JD; Petkova E; Foa EB; Liebowitz MR
J Clin Psychiatry; 2006 Feb; 67(2):269-76. PubMed ID: 16566623
[TBL] [Abstract][Full Text] [Related]
6. An integrated approach to treatment of obsessive compulsive disorder.
Greist JH
J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
[TBL] [Abstract][Full Text] [Related]
7. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study.
Feng B; Zhang ZJ; Zhu RM; Yuan GZ; Luo LY; McAlonan GM; Xu FZ; Chen J; Liu LY; Lv YY; Wong HK; Zhang Y; Zhu LX
J Psychiatr Res; 2016 Sep; 80():30-37. PubMed ID: 27281260
[TBL] [Abstract][Full Text] [Related]
9. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
Simpson HB; Gorfinkle KS; Liebowitz MR
J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
[TBL] [Abstract][Full Text] [Related]
10. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P
J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
[TBL] [Abstract][Full Text] [Related]
11. Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research.
Simpson HB; Petkova E; Cheng J; Huppert J; Foa E; Liebowitz MR
J Psychiatr Res; 2008 Jul; 42(8):631-8. PubMed ID: 17892885
[TBL] [Abstract][Full Text] [Related]
12. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
van Oppen P; van Balkom AJ; Smit JH; Schuurmans J; van Dyck R; Emmelkamp PM
J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
[TBL] [Abstract][Full Text] [Related]
13. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Milanfranchi A; Ravagli S; Lensi P; Marazziti D; Cassano GB
Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
[TBL] [Abstract][Full Text] [Related]
15. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials.
Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB
Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912
[TBL] [Abstract][Full Text] [Related]
16. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Mundo E; Maina G; Uslenghi C
Int Clin Psychopharmacol; 2000 Mar; 15(2):69-76. PubMed ID: 10759337
[TBL] [Abstract][Full Text] [Related]
17. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
18. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.
Fallon BA; Liebowitz MR; Campeas R; Schneier FR; Marshall R; Davies S; Goetz D; Klein DF
Arch Gen Psychiatry; 1998 Oct; 55(10):918-24. PubMed ID: 9783563
[TBL] [Abstract][Full Text] [Related]
19. Standard criteria for relapse are needed in obsessive-compulsive disorder.
Simpson HB; Franklin ME; Cheng J; Foa EB; Liebowitz MR
Depress Anxiety; 2005; 21(1):1-8. PubMed ID: 15806597
[TBL] [Abstract][Full Text] [Related]
20. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
